SUSTAINABLE DEVELOPMENT
The world's leading synthetic biology practitioner
Visioning
Hongjian Bio's capital plan for the next 5 years
Achieve annual revenue of RMB 500 million and apply for listing on the Science and Technology Board.
2022
Establish a synthetic biology industrial base for rapid industrialisation
2023
Strengthen investment in R&D, declare as a national high-tech enterprise and achieve sales revenue of over RMB 100 million
2024
Expand production capacity to achieve annual revenue of 200-300 million RMB.
Create provincial and national innovation platforms.
2025
Set up academician expert workstation
Apply for listing on the Science and Technology Venture Board
Tel